We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.69B
AUM Growth
+$546M
(+11%)
Cap. Flow
+$263M
Cap. Flow
% of AUM
4.63%
Top 10 Holdings %
Top 10 Hldgs %
11.85%
Holding
1,134
New
196
Increased
491
Reduced
251
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$35.7M |
| 2 |
Merck
MRK
|
+$30.3M |
| 3 |
Microsoft
MSFT
|
+$22.4M |
| 4 |
Yum China
YUMC
|
+$17.6M |
| 5 |
Occidental Petroleum
OXY
|
+$17.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$36.5M |
| 2 |
Intel
INTC
|
+$32.4M |
| 3 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$17.1M |
| 4 |
NVR
NVR
|
+$16.3M |
| 5 |
Deere & Co
DE
|
+$16.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Financials | 17.92% |
| 3 | Industrials | 13.48% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Healthcare | 10.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Liquidity Services
LQDT
$1.17B
| $350K | 0.01% |
72,161
+18,735
| +35% | +$102K |
|
827
UMB Financial
UMBF
$10.7B
| $346K | 0.01% |
4,810
-27,170
| -85% | -$2M |
|
828
International Flavors & Fragrances
IFF
$19.4B
| $342K | 0.01% |
2,240
-300
| -12% | -$45.1K |
|
829
Vanda Pharmaceuticals
VNDA
$312M
| $342K | 0.01% |
+22,490
| New | +$334K |
|
830
Applied Materials
AMAT
$426B
| $341K | 0.01% |
+6,670
| New | +$361K |
|
831
Haemonetics
HAE
$3.58B
| $340K | 0.01% |
5,860
| – | – |
|
|
CGI
832
DELISTED
Celadon Group Inc
CGI
| $340K | 0.01% |
+53,200
| New | +$350K |
|
|
HALL
833
DELISTED
Hallmark Financial Services, Inc.
HALL
| $338K | 0.01% |
3,244
+1,657
| +104% | +$184K |
|
834
Vitamin Cottage Natural Grocers
NGVC
$691M
| $336K | 0.01% |
+37,595
| New | +$247K |
|
|
NBL
835
DELISTED
Noble Energy, Inc.
NBL
| $334K | 0.01% |
11,458
-722
| -6% | -$19.8K |
|
836
FS Bancorp
FSBW
$324M
| $332K | 0.01% |
+12,156
| New | +$334K |
|
837
Marchex
MCHX
$79.7M
| $331K | 0.01% |
102,444
-10,285
| -9% | -$32.9K |
|
|
SNBR
838
DELISTED
Sleep Number
SNBR
| $318K | 0.01% |
8,450
-109,961
| -93% | -$3.75M |
|
839
Curis
CRIS
$9.53M
| $316K | 0.01% |
226
+160
| +242% | +$376K |
|
|
INVX
840
Innovex International
INVX
$1.87B
| $315K | 0.01% |
+6,600
| New | +$295K |
|
|
SHLO
841
DELISTED
Shiloh Industries Inc
SHLO
| $315K | 0.01% |
+38,354
| New | +$349K |
|
|
TLRA
842
DELISTED
Telaria, Inc.
TLRA
| $314K | 0.01% |
77,805
-5,900
| -7% | -$25.1K |
|
|
ARC
843
DELISTED
ARC Document Solutions, Inc.
ARC
| $311K | 0.01% |
121,799
+1,175
| +1% | +$3.87K |
|
|
ADVM
844
DELISTED
Adverum Biotechnologies
ADVM
| $310K | 0.01% |
8,859
-310
| -3% | -$10.2K |
|
845
LSI Industries
LYTS
$853M
| $310K | 0.01% |
45,049
+21,599
| +92% | +$146K |
|
846
Movado Group
MOV
$812M
| $304K | 0.01% |
+9,431
| New | +$273K |
|
847
Bassett Furniture
BSET
$169M
| $303K | 0.01% |
8,068
-300
| -4% | -$11.5K |
|
848
Clarus
CLAR
$125M
| $302K | 0.01% |
38,681
+23,596
| +156% | +$177K |
|
|
SCTL
849
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $292K | 0.01% |
35,194
-1,784
| -5% | -$14.6K |
|
|
TCON
850
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $291K | 0.01% |
+434
| New | +$262K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2017 Portfolio in Review
As of Q4 2017, Jacobs Levy Equity Management held 1,134 positions worth $5.69B, up 11% from $5.14B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jacobs Levy Equity Management deployed $263M of net new capital in Q4 2017, opening 196 new positions and adding to 491 existing holdings. Its largest new stake was Yum China: 427,927 shares worth $17.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $36.5M trimmed.
- Jacobs Levy Equity Management's largest Q4 2017 buy was Yum China: 427,927 shares worth $17.1M.
- Jacobs Levy Equity Management added most to Bristol-Myers Squibb in Q4 2017, an estimated $35.7M increase.
- Jacobs Levy Equity Management's biggest Q4 2017 reduction was Johnson & Johnson, cutting an estimated $36.5M.
- Jacobs Levy Equity Management fully exited Twenty-First Century Fox, Inc. Class A in Q4 2017, selling an estimated $17.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 12% of its $5.69B portfolio in Q4 2017.
- Jacobs Levy Equity Management opened 196 new positions and closed 159 in Q4 2017.
- Jacobs Levy Equity Management's portfolio value rose 11% quarter-over-quarter to $5.69B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2017, filed 13 Feb 2018.